Financial

Sequana Medical announces H1 2022 results and provides business update

Financial by 0 comments

alfapump® – strong interim data / on track to report primary endpoint data of North American pivotal POSEIDON study in Q4 2022 DSR® – clinical evidence of disease-modifying heart failure drug therapy / preparations ongoing to start US phase 1b/2a MOJAVE study in H1 2023 Total liquidity position of €23.8 million and cash runway into Q3 2023             Conference call with live webcast presentation today at 03:00 pm CET / 09:00 am ET Ghent, Belgium – 8 September 2022 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” […]

Continue Reading →

Microbot Medical Strengthen its Scientific Advisory Board with the Recent Addition of Dr. Sebastian Flacke

Financial by 0 comments

A global leader in the endovascular space will collaborate with the Company as it goes through the regulatory process and future commercialization HINGHAM, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), which continues to build a reputation within the interventional radiology community for its LIBERTY® Robotic System, […]

Continue Reading →

Conformal Medical Announces Leadership Transition

Financial by 0 comments

Seasoned Medical Device Executive, James Reinstein, Appointed as Chief Executive Officer NASHUA, N.H., Sept. 7, 2022 /PRNewswire/ — Conformal Medical, Inc., a medical device company developing next-generation left atrial appendage occlusion (LAAO) technology, today announced the appointment of James Reinstein as President and Chief Executive Officer. With over three decades in the medical device industry, Reinstein has […]

Continue Reading →

Occlutech Announces New Members to the Executive Management Team – Appoints Chief Commercial Officer and Vice President Global Business Development & Marketing

Financial by 0 comments

SCHAFFHAUSEN, SWITZERLAND / ACCESSWIRE / September 6, 2022 / Occlutech Holding AG Occlutech Holding AG (“Occlutech”), one of the world’s leading providers of minimally invasive structural heart disease devices has expanded its Executive Management Team by appointing two new members. Jose de la Cortina has been recruited as Chief Commercial Officer […]

Continue Reading →

Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Financial by 0 comments

CARLSBAD, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted an equity award on September 1, 2022 that was approved by the Compensation Committee of its Board […]

Continue Reading →

JenaValve Raises $100 Million to Advance Trilogy TAVR Solution

Financial by 0 comments

Financing Secures Funding to Complete ALIGN-AR Clinical Trial, Continue E.U. Real World Evidence Development, and Prepare for a U.S. Commercial Launch IRVINE, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) — JenaValve Technology, Inc. (“JenaValve or the “Company”), developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced that […]

Continue Reading →

Mesoblast Reports Financial Results and Operational Highlights for Fiscal Year Ended June 30, 2022

Financial by 0 comments

At June 30, 2022, cash-on-hand was US$60.4 million with pro-forma US$105.5 million after raising gross proceeds of US$45 million via a private placement in August, 2022 Up to an additional US$40 million available from existing facilities subject to certain milestones Net operating spend of US$65.8 million for the 12 months […]

Continue Reading →

Medtronic completes acquisition of Affera

Financial by 0 comments

Acquisition adds mapping and navigation platform to company’s cardiac ablation portfolio and brings an integrated system of diagnostic and therapeutic tools to address a broad spectrum of arrhythmias DUBLIN, Aug. 30, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it has completed the acquisition of […]

Continue Reading →

LifeTech Scientific Corporation (1302.HK) Announces 2022 Interim Results

Financial by 0 comments

Revenue increased by 20.4%, net profit attributable to owners of the Company increased by 34.4% after excluding certain non-recurring items SHENZHEN, China, Aug. 30, 2022 /PRNewswire/ — LifeTech Scientific Corporation (the “Company” or “Lifetech”), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases announces the unaudited consolidated results of the Company and […]

Continue Reading →
1 … 178 179 180 181 182 … 485